AMSURG partner Giancarlo Mercogliano, M.D, Main Line Endoscopy Center, was interviewed by the Delaware County Daily Times, discussing how more heartburn medications, such as Nexium, are becoming available over-the-counter without a prescription.
AmSurg Corp. (Nasdaq: AMSG) today announced it will release its second quarter 2014 financial results on Thursday, July 31, 2014, after the market closes.
AMSURG partner Darrell Wadas, M.D., Arizona Endoscopy Center, was interviewed by KSAZ Fox 10 in Phoenix with his daughter, Erica, who is a medical student at the University of Arizona and trains alongside her dad.
AMSURG intends to use the net proceeds from these offerings, together with shares of its common stock to be issued in the recently announced transaction between AMSURG and Sheridan Healthcare, Inc.
AMSURG Corp. today announced that its newly formed wholly-owned unrestricted subsidiary AmSurg Escrow Corp. has priced a private offering of $1.1 billion aggregate principal amount of senior unsecured notes due 2022 (the “Notes”).
The Nashville Business Journal recently ranked “Nashville’s top-performing publicly traded companies.”
Congratulations to the following center for successful AAAHC Survey.